The ongoing RESCUE-PATCH Phase I/IIa clinical trial continues to progress at the University Hospitals of Geneva (HUG), evaluating the safety and preliminary efficacy of TrophiPatch™ in patients suffering from chronic, non-healing wounds.

Since the treatment of the first patient in November 2025, patient recruitment has continued and clinical follow-up is ongoing.

The study, sponsored by the Division of Dermatology of HUG and conducted in collaboration with HekeTiss, aims to assess an innovative regenerative therapy based on adipose-derived stromal cells embedded within a gelatin matrix.

As part of its innovation communication activities, HUG recently released a video presenting the clinical trial and the translational journey of this technology, from academic research to clinical evaluation and spin-off development.

We thank HUG, the University of Geneva (UNIGE), and the Fondation privée des HUG for their continued support of this project.

Watch the official video from HUG video

More info here